Olymvax Biopharmaceuticals Inc

Haemophilus influenzae type b (Hib) is capsule typeH.influenzae, whose polysaccharide capsule can make it get away from cell phagocytosis. Through invasion of the blood-stream with secondary spread to other sites, Hib can lead to meningitis, pneumonia, and other serious disease including septic arthritis, sepsis, cellulitis, osteoarthritis etc.

Hib disease is treated usually with antibiotics, which may mostly lead to long-term sequelae. Antibiotic resistant Hib isolates were first reported in 1972, since then resistant strains spread out the world, antibiotics is fading out. Via Hib vaccination, morbidity of Hib diseases in the USA and EU decreased about 99%.